Dr. David Faugno-Fusci, MD

Dr. Faugno-Fusci practices at Sanford Bemidji Medical Center in Bemidji, Minnesota, part of Sanford Health.

Dr. Faugno-Fusci's NPI, 1467983528, was assigned on March 21, 2017. Dr. Faugno-Fusci holds Pennsylvania license MD477246.

Dr. Faugno-Fusci's primary practice is Sanford Bemidji Medical Center, at 1300 Anne St NW, Bemidji, MN 56601 in Beltrami County. The practice phone is (218) 751-5430.

Dr. Faugno-Fusci's primary practice is Sanford Bemidji Medical Center in Bemidji, Minnesota, part of Sanford Health. Dr. Faugno-Fusci is also affiliated with Sanford Broadway Medical Center. The medical group on file is Sanford Health Occupational Medicine Clinic Bismarck. Dmand AI also links Dr. Faugno-Fusci to 1 more hospital, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Faugno-Fusci practices, 6 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Faugno-Fusci's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Faugno-Fusci is licensed in Pennsylvania.

CMS data shows 180 Medicare services from Dr. Faugno-Fusci across 7 procedure codes in 2024, for 174 Medicare patients. Medicare paid $20,698 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 174 Medicare patients who saw Dr. Faugno-Fusci in 2024. The largest group is 65 to 74, with 85 patients. 75% of them have high cholesterol, and 69% have high blood pressure. 20% are also on Medicaid. Their average risk score is 1.32, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Faugno-Fusci's median patient age at 67, with 51% women.

In 2024, Dr. Faugno-Fusci wrote 114 Medicare Part D claims for 54 patients. 91% of them were for generic drugs. CMS names the drug for 81 of them, across 3 drugs with 11 or more claims each, at $2,532 in total drug cost. In 2023, CMS named 27 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Faugno-Fusci for performance year 2024, reported as part of a group. Dr. Faugno-Fusci accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 96 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Faugno-Fusci, more than 76% of the clinicians it reports for that procedure.

Hernia repair (minimally invasive): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Faugno-Fusci in 2023. Dr. Faugno-Fusci's most frequent co-author is Allincia Michaud, MD, MPH.

CMS Open Payments shows 6 general payments to Dr. Faugno-Fusci from 5 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Davol Inc. paid the most, $286.